Ardent Health, Inc. faces a securities class action lawsuit alleging the company failed to disclose material information to investors. On November 12, 2025, the healthcare provider announced a $43 million revenue decline, reduced its 2025 EBITDA guidance by $57.5 million, and increased professional liability reserves by $54 million. The announcements triggered a sharp market reaction, with the company's stock declining 34% from $14.05 to $9.30 per share.
The lawsuit alleges that Ardent Health withheld critical financial and operational information that should have been disclosed to shareholders earlier. Investors who sustained losses exceeding $100,000 during the relevant period are eligible to file lead plaintiff applications in the litigation. The deadline for submitting such applications is March 9, 2026.
Lead plaintiff status allows qualified investors to direct the litigation strategy and potentially recover damages through settlement or judgment. Shareholders interested in pursuing this action should consult with legal counsel regarding their eligibility and the filing requirements.